 | • レポートコード：MRC2012A6738 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、市販（OTC）薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。市販（OTC）薬の種類別市場規模（風邪・インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、Teva Pharmaceuticals、Novartis、Boehringer Ingelheim、Sanofi、GSK、Cipla、PGT healthcare、Pfizer、Takeda、Sun Pharmaceutical Industries、Glenmark、Innovus Pharmaceuticals、 ・地域別グローバル市場分析 2015年-2020年 ・市販（OTC）薬の北米市場（アメリカ、カナダ、メキシコ） ・市販（OTC）薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・市販（OTC）薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・市販（OTC）薬の南米市場（ブラジル、アルゼンチン） ・市販（OTC）薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：風邪・インフルエンザ製品、鎮痛剤、皮膚科製品、胃腸製品、ビタミン、その他 ・用途別分析：病院薬局、小売薬局、オンライン薬局 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Over-The-Counter (OTC) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Over-The-Counter (OTC) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Over-The-Counter (OTC) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Over-The-Counter (OTC) Drugs market has been segmented into
Cold and Flu Products
Analgesics
Dermatological Products
Gastrointestinal Products
Vitamin
Other
By Application, Over-The-Counter (OTC) Drugs has been segmented into:
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Over-The-Counter (OTC) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Over-The-Counter (OTC) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Over-The-Counter (OTC) Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Over-The-Counter (OTC) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Over-The-Counter (OTC) Drugs Market Share Analysis
Over-The-Counter (OTC) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Over-The-Counter (OTC) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Over-The-Counter (OTC) Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Over-The-Counter (OTC) Drugs are:
Bayer
Teva Pharmaceuticals
Novartis
Boehringer Ingelheim
Sanofi
GSK
Cipla
PGT healthcare
Pfizer
Takeda
Sun Pharmaceutical Industries
Glenmark
Innovus Pharmaceuticals
Among other players domestic and global, Over-The-Counter (OTC) Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Over-The-Counter (OTC) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Over-The-Counter (OTC) Drugs, with price, sales, revenue and global market share of Over-The-Counter (OTC) Drugs in 2018 and 2019.
Chapter 3, the Over-The-Counter (OTC) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Over-The-Counter (OTC) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Over-The-Counter (OTC) Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Over-The-Counter (OTC) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Over-The-Counter (OTC) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Over-The-Counter (OTC) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Cold and Flu Products
1.2.3 Analgesics
1.2.4 Dermatological Products
1.2.5 Gastrointestinal Products
1.2.6 Vitamin
1.2.7 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Over-The-Counter (OTC) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 Overview of Global Over-The-Counter (OTC) Drugs Market
1.4.1 Global Over-The-Counter (OTC) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Teva Pharmaceuticals
2.2.1 Teva Pharmaceuticals Details
2.2.2 Teva Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Teva Pharmaceuticals SWOT Analysis
2.2.4 Teva Pharmaceuticals Product and Services
2.2.5 Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Boehringer Ingelheim
2.4.1 Boehringer Ingelheim Details
2.4.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Boehringer Ingelheim SWOT Analysis
2.4.4 Boehringer Ingelheim Product and Services
2.4.5 Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanofi SWOT Analysis
2.5.4 Sanofi Product and Services
2.5.5 Sanofi Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GSK SWOT Analysis
2.6.4 GSK Product and Services
2.6.5 GSK Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cipla SWOT Analysis
2.7.4 Cipla Product and Services
2.7.5 Cipla Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 PGT healthcare
2.8.1 PGT healthcare Details
2.8.2 PGT healthcare Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 PGT healthcare SWOT Analysis
2.8.4 PGT healthcare Product and Services
2.8.5 PGT healthcare Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Pfizer SWOT Analysis
2.9.4 Pfizer Product and Services
2.9.5 Pfizer Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Takeda
2.10.1 Takeda Details
2.10.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Takeda SWOT Analysis
2.10.4 Takeda Product and Services
2.10.5 Takeda Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sun Pharmaceutical Industries
2.11.1 Sun Pharmaceutical Industries Details
2.11.2 Sun Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sun Pharmaceutical Industries SWOT Analysis
2.11.4 Sun Pharmaceutical Industries Product and Services
2.11.5 Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Glenmark
2.12.1 Glenmark Details
2.12.2 Glenmark Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Glenmark SWOT Analysis
2.12.4 Glenmark Product and Services
2.12.5 Glenmark Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Innovus Pharmaceuticals
2.13.1 Innovus Pharmaceuticals Details
2.13.2 Innovus Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Innovus Pharmaceuticals SWOT Analysis
2.13.4 Innovus Pharmaceuticals Product and Services
2.13.5 Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Over-The-Counter (OTC) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Over-The-Counter (OTC) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Over-The-Counter (OTC) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Over-The-Counter (OTC) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Over-The-Counter (OTC) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Over-The-Counter (OTC) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Over-The-Counter (OTC) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
4.5 South America Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Over-The-Counter (OTC) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Over-The-Counter (OTC) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Over-The-Counter (OTC) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Over-The-Counter (OTC) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Over-The-Counter (OTC) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Over-The-Counter (OTC) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
6.3 UK Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
6.4 France Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Over-The-Counter (OTC) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Over-The-Counter (OTC) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Over-The-Counter (OTC) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
7.5 India Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Over-The-Counter (OTC) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Over-The-Counter (OTC) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Over-The-Counter (OTC) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Over-The-Counter (OTC) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Over-The-Counter (OTC) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Over-The-Counter (OTC) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Over-The-Counter (OTC) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Over-The-Counter (OTC) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Over-The-Counter (OTC) Drugs Price by Type (2015-2020)
11 Global Over-The-Counter (OTC) Drugs Market Segment by Application
11.1 Global Over-The-Counter (OTC) Drugs Sales Market Share by Application (2015-2020)
11.2 Global Over-The-Counter (OTC) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Over-The-Counter (OTC) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Over-The-Counter (OTC) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Over-The-Counter (OTC) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Over-The-Counter (OTC) Drugs Market Forecast (2021-2025)
12.2.2 Europe Over-The-Counter (OTC) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Over-The-Counter (OTC) Drugs Market Forecast (2021-2025)
12.2.4 South America Over-The-Counter (OTC) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Over-The-Counter (OTC) Drugs Market Forecast (2021-2025)
12.3 Over-The-Counter (OTC) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Over-The-Counter (OTC) Drugs Market Share Forecast by Type (2021-2025)
12.4 Over-The-Counter (OTC) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Over-The-Counter (OTC) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Over-The-Counter (OTC) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Over-The-Counter (OTC) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Over-The-Counter (OTC) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Over-The-Counter (OTC) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Over-The-Counter (OTC) Drugs Major Business
Table 9. Bayer Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Bayer SWOT Analysis
Table 11. Bayer Over-The-Counter (OTC) Drugs Product and Services
Table 12. Bayer Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Major Business
Table 15. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 16. Teva Pharmaceuticals SWOT Analysis
Table 17. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Product and Services
Table 18. Teva Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Over-The-Counter (OTC) Drugs Major Business
Table 21. Novartis Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Novartis SWOT Analysis
Table 23. Novartis Over-The-Counter (OTC) Drugs Product and Services
Table 24. Novartis Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 26. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Major Business
Table 27. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 28. Boehringer Ingelheim SWOT Analysis
Table 29. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Product and Services
Table 30. Boehringer Ingelheim Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Over-The-Counter (OTC) Drugs Major Business
Table 33. Sanofi Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Sanofi SWOT Analysis
Table 35. Sanofi Over-The-Counter (OTC) Drugs Product and Services
Table 36. Sanofi Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. GSK Basic Information, Manufacturing Base and Competitors
Table 38. GSK Over-The-Counter (OTC) Drugs Major Business
Table 39. GSK Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 40. GSK SWOT Analysis
Table 41. GSK Over-The-Counter (OTC) Drugs Product and Services
Table 42. GSK Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Cipla Basic Information, Manufacturing Base and Competitors
Table 44. Cipla Over-The-Counter (OTC) Drugs Major Business
Table 45. Cipla Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Cipla SWOT Analysis
Table 47. Cipla Over-The-Counter (OTC) Drugs Product and Services
Table 48. Cipla Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. PGT healthcare Basic Information, Manufacturing Base and Competitors
Table 50. PGT healthcare Over-The-Counter (OTC) Drugs Major Business
Table 51. PGT healthcare Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 52. PGT healthcare SWOT Analysis
Table 53. PGT healthcare Over-The-Counter (OTC) Drugs Product and Services
Table 54. PGT healthcare Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Pfizer Basic Information, Manufacturing Base and Competitors
Table 56. Pfizer Over-The-Counter (OTC) Drugs Major Business
Table 57. Pfizer Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 58. Pfizer SWOT Analysis
Table 59. Pfizer Over-The-Counter (OTC) Drugs Product and Services
Table 60. Pfizer Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Takeda Basic Information, Manufacturing Base and Competitors
Table 62. Takeda Over-The-Counter (OTC) Drugs Major Business
Table 63. Takeda Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 64. Takeda SWOT Analysis
Table 65. Takeda Over-The-Counter (OTC) Drugs Product and Services
Table 66. Takeda Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 68. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Major Business
Table 69. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 70. Sun Pharmaceutical Industries SWOT Analysis
Table 71. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Product and Services
Table 72. Sun Pharmaceutical Industries Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. Glenmark Basic Information, Manufacturing Base and Competitors
Table 74. Glenmark Over-The-Counter (OTC) Drugs Major Business
Table 75. Glenmark Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 76. Glenmark SWOT Analysis
Table 77. Glenmark Over-The-Counter (OTC) Drugs Product and Services
Table 78. Glenmark Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Innovus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 80. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Major Business
Table 81. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Total Revenue (USD Million) (2017-2018)
Table 82. Innovus Pharmaceuticals SWOT Analysis
Table 83. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Product and Services
Table 84. Innovus Pharmaceuticals Over-The-Counter (OTC) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Global Over-The-Counter (OTC) Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 86. Global Over-The-Counter (OTC) Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 87. Global Over-The-Counter (OTC) Drugs Sales by Regions (2015-2020) (K Units)
Table 88. Global Over-The-Counter (OTC) Drugs Sales Market Share by Regions (2015-2020)
Table 89. Global Over-The-Counter (OTC) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 90. North America Over-The-Counter (OTC) Drugs Sales by Countries (2015-2020) (K Units)
Table 91. North America Over-The-Counter (OTC) Drugs Sales Market Share by Countries (2015-2020)
Table 92. North America Over-The-Counter (OTC) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 93. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2015-2020)
Table 94. Europe Over-The-Counter (OTC) Drugs Sales by Countries (2015-2020) (K Units)
Table 95. Europe Over-The-Counter (OTC) Drugs Sales Market Share by Countries (2015-2020)
Table 96. Europe Over-The-Counter (OTC) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 97. Asia-Pacific Over-The-Counter (OTC) Drugs Sales by Regions (2015-2020) (K Units)
Table 98. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Regions (2015-2020)
Table 99. Asia-Pacific Over-The-Counter (OTC) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 100. South America Over-The-Counter (OTC) Drugs Sales by Countries (2015-2020) (K Units)
Table 101. South America Over-The-Counter (OTC) Drugs Sales Market Share by Countries (2015-2020)
Table 102. South America Over-The-Counter (OTC) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 103. South America Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2015-2020)
Table 104. Middle East & Africa Over-The-Counter (OTC) Drugs Sales by Countries (2015-2020) (K Units)
Table 105. Middle East & Africa Over-The-Counter (OTC) Drugs Sales Market Share by Countries (2015-2020)
Table 106. Middle East & Africa Over-The-Counter (OTC) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 107. Middle East & Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2015-2020)
Table 108. Global Over-The-Counter (OTC) Drugs Sales by Type (2015-2020) (K Units)
Table 109. Global Over-The-Counter (OTC) Drugs Sales Share by Type (2015-2020)
Table 110. Global Over-The-Counter (OTC) Drugs Revenue by Type (2015-2020) (USD Million)
Table 111. Global Over-The-Counter (OTC) Drugs Revenue Share by Type (2015-2020)
Table 112. Global Over-The-Counter (OTC) Drugs Sales by Application (2015-2020) (K Units)
Table 113. Global Over-The-Counter (OTC) Drugs Sales Share by Application (2015-2020)
Table 114. Global Over-The-Counter (OTC) Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 115. Global Over-The-Counter (OTC) Drugs Market Share Forecast by Regions (2021-2025)
Table 116. Global Over-The-Counter (OTC) Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 117. Global Over-The-Counter (OTC) Drugs Market Share Forecast by Type (2021-2025)
Table 118. Global Over-The-Counter (OTC) Drugs Sales Forecast by Application (2021-2025)
Table 119. Global Over-The-Counter (OTC) Drugs Market Share Forecast by Application (2021-2025)
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Over-The-Counter (OTC) Drugs Picture
Figure 2. Global Sales Market Share of Over-The-Counter (OTC) Drugs by Type in 2019
Figure 3. Cold and Flu Products Picture
Figure 4. Analgesics Picture
Figure 5. Dermatological Products Picture
Figure 6. Gastrointestinal Products Picture
Figure 7. Vitamin Picture
Figure 8. Other Picture
Figure 9. Over-The-Counter (OTC) Drugs Sales Market Share by Application in 2018
Figure 10. Hospital Pharmacy Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Online Pharmacy Picture
Figure 13. Global Over-The-Counter (OTC) Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Over-The-Counter (OTC) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Over-The-Counter (OTC) Drugs Sales Market Share by Manufacturer in 2019
Figure 34. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Over-The-Counter (OTC) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Over-The-Counter (OTC) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 39. Global Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Regions (2015-2020)
Figure 41. Global Over-The-Counter (OTC) Drugs Revenue Market Share by Regions in 2018
Figure 42. North America Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
Figure 43. Europe Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
Figure 45. South America Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020)
Figure 47. North America Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Over-The-Counter (OTC) Drugs Sales Market Share by Countries (2015-2020)
Figure 49. North America Over-The-Counter (OTC) Drugs Sales Market Share by Countries in 2018
Figure 50. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Over-The-Counter (OTC) Drugs Revenue Market Share by Countries in 2018
Figure 52. United States Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Canada Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Mexico Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 55. Europe Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Over-The-Counter (OTC) Drugs Revenue Market Share by Countries in 2019
Figure 58. Germany Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. UK Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. France Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Russia Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Italy Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Asia-Pacific Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Over-The-Counter (OTC) Drugs Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Over-The-Counter (OTC) Drugs Revenue Market Share by Regions 2019
Figure 66. China Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Japan Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Korea Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. India Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Southeast Asia Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 71. South America Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Over-The-Counter (OTC) Drugs Sales Market Share by Countries in 2019
Figure 73. South America Over-The-Counter (OTC) Drugs Revenue Market Share by Countries in 2019
Figure 74. Brazil Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Argentina Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Over-The-Counter (OTC) Drugs Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Over-The-Counter (OTC) Drugs Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Egypt Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Turkey Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. South Africa Over-The-Counter (OTC) Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 84. Global Over-The-Counter (OTC) Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 85. Global Over-The-Counter (OTC) Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Over-The-Counter (OTC) Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Europe Sales Over-The-Counter (OTC) Drugs Market Forecast (2021-2025) (K Units)
Figure 88. Asia-Pacific Sales Over-The-Counter (OTC) Drugs Market Forecast (2021-2025) (K Units)
Figure 89. South America Sales Over-The-Counter (OTC) Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Middle East & Africa Sales Over-The-Counter (OTC) Drugs Market Forecast (2021-2025) (K Units)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel
市販薬（OTC）の世界市場（～2026年） Market Analysis and Insights: Global Over-The-Counter (OTC) Drugs Market The global Over-The-Counter (OTC) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Over-The-Counter (OTC) Drugs Scope and Market Size Over-T…- OTC薬の世界市場（～2026年） OTC drugs are medicines that can be bought without a prescription from a doctor. The lenient regulatory framework and the availability of several distribution channels to be some of the major factors that will have a positive impact on the growth of this market in the coming years. Market Analysis a…
- 市販用診断製品の世界市場（～2026年） Market Analysis and Insights: Global Over-the-Counter Diagnostic Products Market The global Over-the-Counter Diagnostic Products market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Over-the-Counter Diagnostic Products Scop…
- カウンターUAVの世界市場（～2026年） Counter-drone technology, also known as counter-UAS, C-UAS, or counter-UAV technology, refers to systems that are used to detect and/or intercept unmanned aircraft. As concerns grow around the potential security threats drones may pose to both civilian and military entities, a new market for counter…
- 処方用皮膚科薬の世界市場（～2026年） Market Analysis and Insights: Global Prescription Dermatological Drugs Market The global Prescription Dermatological Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prescription Dermatological Drugs Scope and Mar…